ArticleACS omega2025
Cellular Responses to Hydrophobic Polyelectrolyte/Wax Coatings for Biomedical Use.
Article in ACS omega, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- A Composite Based onPolymers · 2026Article
- Composite Coating-driven Regulation ofIn vivo (Athens, Greece)Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Polyelectrolyte multilayer (PEM) coatings represent a promising strategy for the biofunctionalization of biomaterials. Incorporating nonpolymeric components into the polymer matrix is a strategy to modulate PEM properties, enabling the development of new, application-specific functionalities. For example, integrating nano-thick wax layers both within and atop the PEM matrix creates hydrophobic waterproof barrier coatings that show great potential for use on bioresorbable magnesium implants. These coatings hinder contact between the implant and surrounding tissue and bodily fluids, thereby slowing down implants' degradation. However, the hydrophobic nature of such coatings raises concerns regarding their cell compatibility and overall biocompatibility. This study investigates and compares the viability of fibroblasts (3T3 cells) and human umbilical vein endothelial cells (HUVECs) on three different hydrophilic PEM coatings and their corresponding composite hydrophobic PEM/Wax counterparts. Our results show that some aspects of cellular behavior are cell-type-specific, while others are commonly influenced by the chemical composition of the coatings. Although hydrophobic, all three PEM/Wax coatings supported fibroblast adhesion and growth, surpassing their hydrophilic PEM counterparts, whereas the more surface- and environment-sensitive HUVECs showed reduced adhesion and viability on the hydrophobic coatings compared with the hydrophilic PEMs. Cytotoxicity testing, conducted in accordance with ISO 10993-5, confirmed that all coatings are noncytotoxic, supporting their suitability for use in medical devices.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.